Pivotal bioVenture Partners Investment Advisor LLC
Venture CapitalPosition in TRVI — Trevi Therapeutics, Inc.
CIK 1844645
SAN FRANCISCO, CA
Position in TRVI
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$18,535,951
+$2,801,041 QoQ
Shares Held
1,553,726
+23.6% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
6.63%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pivotal bioVenture Partners Investment Advisor LLC holds $268,178,415 across 11 Biotechnology names. TRVI ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
1,372,425 | $79,751,616 | |
| 2 | OCS |
Oculis Holding AG
|
1,680,283 | $44,678,724 | |
| 3 | EVMN |
Evommune, Inc.
|
1,926,943 | $44,300,419 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,355,892 | $31,944,815 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
This page
|
1,553,726 | $18,535,951 | |
| 6 | IMNM |
Immunome Inc.
|
732,512 | $16,020,037 | |
| 7 | MPLT |
MapLight Therapeutics, Inc.
|
611,447 | $12,430,717 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
591,991 | $11,573,424 |
All Filings in TRVI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,535,951 | 1,553,726 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $15,734,910 | 1,256,782 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,499,555 | 1,256,782 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,269,221 | 1,146,110 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||